Jilin Changlong Pharmaceutical (08049) announced results for the year ended December 31, 2023, and the group obtained revenue...
According to the Zhitong Finance App, Jilin Changlong Pharmaceutical (08049) announced results for the year ended December 31, 2023. The group obtained revenue of RMB 842 million (same unit), which was the same as the previous year; profit attributable to the company's owners was 148 million yuan, a decrease of 23.43% year on year; profit per share was 26.45 points.